chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received dose 1 of covid 19 vaccine on 20 APR 21. Within 24 hours, patient reported onset of rash "like mosquito bites" on lower arms. States rash developed into more hive like appearance and spread up arms and onto trunk. From there, spread down legs and up onto face. States saw PCM, Dr. who stated rash may or may not have been caused by vaccine. Patient recently moved. This is her first time living in this area. This area is at height of allergen season with high pollen counts. Patient self reports she was instructed to begin taking daily allergy med (doesn't remember if claritin or zyrtec) and has been taking that medication since seeing PCM. She has also received referral for allergist but has yet to make appointment. Hives still persist on her arms and legs today - nearly 2 months post start.
Light headedness; dizziness; numb lips; sore arm; very low heart rate (45 bpm);
L arm bruised, swollen, very sore. Patient felt fatigue, headache. Advised mom to give IBUPROFEN, use heat/ice PRN at injection site.
-Mom contacted me   11 days  after shot.  Said after shot, child was unresponsive  to sound, blinking, loss of appetite  for 3 hours. Requested  exemption from all vaccines.
MILD WHEEZING, "OFF BALANCE" Equilibrium OFF, HEADACHE AND EYES STARTED ITCHING AROUND 11:00PM, EYES WHERE SWOLLEN BY 05:15AM THE NEXT MORNING, LATER ON 10/16/09-HEART STARTED RACING. SWOLLEN EYES OVER THE NEXT 2 DAYS WITH A MILD SORE THROAT. TOOK BENADRYL TO KEEP REACTION DOWN.I STILL HAVE MILD SWELLING TO MY EYES BUT CAN'T TAKE ANY BENADRYL WHILE ON DUTY..TODAY IS 10/18/2009. THROAT IS STILL SCRATCHY, MILD WHEEZES INTERMITTENTLY. I DIDN'T GO TO THE DOCTOR'S TO PAY FOR SOMETHING I ALREADY KNOW HOW TO TREAT..IF I CAN'T MAINTAIN ON MY OWN, THEN I WILL GO.
Rigors, fever (102 F) and muscle aches starting about 13 hours after dose and not resolving until about 48 hours after dose. From 48 hour to approximately 72 hours there remained achiness and a headache that I would rate at a 7/10 on a 0/10 scale. Tylenol and Ibuprofen was used throughout episode with little impact to pain or fever.
fever , cough, tiredness , body aches  Office Visit 4/30/2021 Urgent Care  CRNP Family Medicine COVID-19 Dx Cough  Reason for Visit Progress Notes (Nurse Practitioner) ? ? Family Medicine ? ? Encounter Date: 4/30/2021 ? ? Signed Expand AllCollapse All    History  Chief Complaint Patient presents with ? Cough     Lingering fatigue, fever   Positive Covid test 4-26-21     Patient is a 51 y.o. male    HPI   Patient is a 51-year-old male who presents with continued Covid symptoms.  Patient was diagnosed on April 26.  He is currently on day 9 of symptoms.  Patient continues to have low-grade fevers.  Wife and patient would like the cough is worse.  He has been taking over-the-counter medications with minimal relief.  He denies history of pneumonia or asthma. Symptoms started suddenly and have been persistent.    Tmax at home = 100.4 F  Admits to nasal congestion,  rhinorrhea, sinus pressure,  nonproductive cough  Denies  ear pain,  sore throat The cough is worse at nighttime.  Admits to occasional mild chest tightness.
pt reported slightly light headed ,felt like her neck was warm and left gland swollen, about 1/2 hour after vaccine, denied any difficulty swallowing, sob or chest pain(reported she had vaccine at other pharmacy and was fine after waiting 15 min.
1-13-10- had rash this morning noticed when changing. No fever with shot. Has confluent erythematic maculopapular rash on trunk has local reaction to H1N1 shot no dyspnoea or wheezing. Adverse reaction to vaccine or polytrim drops will stop polytrim-switch to Gentamicin drops.
Tongue turned a reddish purple and the lips and tongue swelled and it was difficult to talk with lips swelled up.  In addition the lips still are sore in January.
Shooting pain behind right ear and stiff neck (right side).  Joint aches. (knees)
Blood clot in her lungs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY EMBOLISM (Blood clot in her lungs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PULMONARY EMBOLISM (Blood clot in her lungs) (seriousness criterion medically significant). At the time of the report, PULMONARY EMBOLISM (Blood clot in her lungs) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.  The action taken with mRNA 1273 with the events was considered as not applicable.  Company comment: Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
Pt reports he had Janssen booster on 12/3/21 at the pharmacy. Patient reports he was out of town fishing and started to notice he was having severe chest pain. Pt called emergency number and was taken to hospital then transferred to medical center. Pt reports they did CT scans and x-ray.  Then was determined several blood clots in both lungs. Pt reports they did angioplasty.  Pt was sent home on Eliquis 5mg PO daily and atorvastatin 400mg PO daily.  Pt reports he is scheduled to see a hematologist and cardiologist. Pt unknown of appointment schedule.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021 at 1:16 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2021 at 1:16 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 52.85 on 14-Feb-2021.  Concomitant products were not provided.  On 14-Feb-2021, Excursion time was 09 AM, temperature was 32, 10 AM the temperature was 32, 11 AM the temperature was 32, 02 PM the temperature was 35 and 3 PM the temperature was 35, total doses given for the day was 162, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021 (Batch number: 031L20A).  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
PATIENT COMPLAINS THAT HER LEFT ARM HAS BEEN HURTING HER SINCE ADMISTRATION ON 10/9/2020 UNTIL TODAY 1/6/2021
The patient came to the emergency room with shortness of breath.  Then patient was diagnosed with COVID-19 pneumonia.  Then patient was started on remdesivir and steroids.  Patient started feeling better and patient started breathing on room air.  Patient also had acute kidney injury that also got resolved.  Since patient was stable enough after 5 days, patient was be discharged home.
Patient came to urgent care today reporting intermittent midsternal chest pain that radiated up the right side of his neck for one hour (around 3:30PM), the day after receiving his first COVID vaccine in the right arm.  Patient reports 7/10 pain when the tightness/pain came.  BP elevated, but all other vitals within normal limits.  EKG performed.  Recommendation patient go to Emergency Room for further workup.
48 hours after my shot, I woke up with 100% hearing loss, pressure in both ears and a migraine type headache. Since that day, I have been prescribed Prednisone and countless antihistamine and antibiotics to try and relieve this issue. The only thing that works is prednisone. Once it?s done, hearing loss returns. Migraines are daily.
URI sxs 16Jun;then severe joint pain-knees, thumbs, spine, primarily hips-unable to walk for 2 days.Gen'l malaise.After 3-4 days sxs resolved except of achiness of knees which as of 29Jun is very slight.No fever.Motrin gave little relief.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 02-JUN-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength: 0.5ml) (lot # L036245, expiration date 09-FEB-2018). No adverse effects were reported. This specified lot number was exposed to temperature excursion for three times. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (refrigerator/freezer) (R/F) for the first and second time were 828, 29 and R; 212, 34 and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree) and the type of excursion (refrigerator/freezer) (R/F) for the third time were 24, 49 and R. The storage criteria was R. This is one of several reports received from the same source. Additional information has been requested.
HEART RATE HIGH; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure. The patient was on beta blockers and high blood pressure medications. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) frequency 1 total, dose, start therapy date were not reported for prophylactic vaccination.The batch number was not reported. Per procedure, no follow-up will be requested for this case. On an unspecified date, the patient experienced heart rate high. Patient was hospitalized (date unspecified) for 3 days with a code blue called. Patient wore a fitbit and had a record of heart rate for a year.152 sitting was too high. On an unspecified date in 2021, Laboratory data included: Heart rate (NR: not provided) 152. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse reaction was not reported. This report was serious (Hospitalization Caused / Prolonged); Sender's Comments: V0: 20210504075-COVID-19 VACCINE  AD26.COV2.S-Heart Rate High. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
My husband woke up with severe pain in his right arm the morning after the injection. He saw Dr. a couple of weeks later at which time the Dr said the tetanus injection could not have caused the pain.  After xray and MRI it was found that he had a partially torn bicep and rotator cuff which could not have been caused by injection.  But somehow it has affected his arm.  He has been on physical therapy for several weeks now but has lost some motion in that arm and has some pain in the left arm also which started at the same time as the arm of injection.
PT HAD SEIZURE AT 8:10 AM ON 6/10/21.  PT HAS A DIAGNOSIS OF UNSPECIFIED CONVULSIONS   ADDITIONAL MEDS: BACLOFEN 20 MG, CELEXA 10MG, CALCIUM CARBONATE- VITA D3 600-400 MG, DILANTIN 100 MG BID, LISINOPRIL 10-12.5MG, GABEPENTIN 300MG, MELOXICAM 7.5 MG,
Guillain-Barré Syndrome, nearly killed her; paralyzed, in a wheel chair; paralyzed, in a wheel chair; Pain; This case was reported by a consumer via call center representative and described the occurrence of guillain barre syndrome in a female patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   The patient's past medical history included pneumonia (pneumonia at 2 weeks old), difficulty breathing (breathing problems (colds, bronchitis, pneumonia) when she was in her late 20's), cold, bronchitis, numbness of lower extremities and passive smoking (never smoked (inhaled second hand smoke as a child)). Previously administered products included Brovana (Brovana (arformoterol)-was using this product for a few years but it started to wear off after about 2 hours also was hospitalized due to it causing her legs/feet numb). Concurrent medical conditions included drug allergy (Allergic to propellant in Proventil - was in hospital for 2 weeks) and allergic asthma (allergy related asthma).   On an unknown date, the patient received Influenza vaccine. On an unknown date, less than a year after receiving Influenza vaccine, the patient experienced guillain barre syndrome (serious criteria GSK medically significant and life threatening), paralysis (serious criteria GSK medically significant), wheelchair user and pain. The patient was treated with morphine. On an unknown date, the outcome of the guillain barre syndrome, paralysis, wheelchair user and pain were recovered/resolved.   The reporter considered the guillain barre syndrome, paralysis, wheelchair user and pain to be related to Influenza vaccine.  Additional Information: GSK Receipt Date: 28-OCT-2022 Reporter's Comment: The reporter was the patient.  She did not want to provide her street address nor did she want to answer any further questions as she did not want a report to be filed.  The reporter was calling to ask questions about Trelegy.  She had not started using Trelegy yet but was given samples.  She was asking if it was okay to use ipratropium bromide 0.2 percent nebulizer solution prior to inhaling Trelegy During the call, she mentioned many of her medical conditions (present and past) and indicated that in 2005 she developed GBS (Guillain-Barre Syndrome) due to receiving a flu shot. The patient received flu shot in 2005. She did not remember the name of the specific flu shot she had received.  She said that the GBS nearly killed her and that it took her 2 years to get over it from the day of reporting. She said that, she was paralyzed and in a wheel chair and was taking mega doses of morphine for the pain. On 27th October 2022, used Albuterol nebulizing solution 0.083 percent and had it make her feel shaky for 2-3 hours. The reporter did not want to answer any further questions and did not want a report to be filed.
Palpitations and chest pain immediately after infection  Lasted about 60 seconds. Palpitations came and went until the next day.
she felt hot from her forehead down to the top of her neck - it was red and warm to touch; she felt hot from her forehead down to the top of her neck - it was red and warm to touch; This spontaneous case was reported by a patient and describes the occurrence of SKIN WARM (she felt hot from her forehead down to the top of her neck - it was red and warm to touch) and ERYTHEMA (she felt hot from her forehead down to the top of her neck - it was red and warm to touch) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.    Co-suspect product included non-company product ACETYLSALICYLIC ACID (ASPIRINA-G) for Anticoagulant therapy.    Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form and ACETYLSALICYLIC ACID (ASPIRINA-G) (unknown route) at an unspecified dose. On an unknown date, the patient experienced SKIN WARM (she felt hot from her forehead down to the top of her neck - it was red and warm to touch) and ERYTHEMA (she felt hot from her forehead down to the top of her neck - it was red and warm to touch). At the time of the report, SKIN WARM (she felt hot from her forehead down to the top of her neck - it was red and warm to touch) and ERYTHEMA (she felt hot from her forehead down to the top of her neck - it was red and warm to touch) had resolved.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   It was reported that patient was on blood thinner. She stated that she had the 4 Moderna vaccines and after the 1st dose, she felt hot from her forehead down to the top of her neck - it was red and warm to touch. She did not have this after the succeeding doses as she took Benadryl before and after the injections. She says that she's been on Aspirin even before she took the 1st dose of the Moderna Covid-19 vaccine. No treatment information was provided.
4 days after 2nd dose of vaccine arm began turning red at injection site and extended down the arm to elbow
Starting about 12 hours after vaccination I had severe cramps in my mid back - like a charlie horse in the bottom of the foot. Very painful, muscle relaxers took the edge off, but was still painful. Severe cramps lasted about 6 hours.  This is the same thing that happened to me during the 2nd dose, except with the 2nd dose the cramps lasted closer to 12 hours.   About 28 hours after vaccination I had moderate hives on my neck, shoulders chest and scalp. I treated with benadryl and monitored closely. Hives had disappated after about 12 hours more. However, I have had several unexplained breakouts in hives in the month since the booster shot.   I did not have any hives with the 1st or 2nd dose, only the booster shot (3rd dose).  Other symptoms included: headache for about 40 hours, starting approximately 12 hours after dose. Heat, and soreness at the injection site. Mild fever, some chills, and some dizziness. Dizzyness was mild with the booster, but substantial with the 2nd dose (so much so I had to crawl to the restroom because I couldn't remain upright).
pt recv vax 3JUN96 & 30JUN96 pt exp two lesions under arm & on back;during that wk  pt devel more lesions mostly under arm;@ time of report there were approx 20 lesions;
Within 15 minutes of injections, the patient broke out in a hot, burning/itchy red rash all over her upper body. It spread down both arms and I could see it spreading up her chest and neck. We administered 25 mg oral Benadryl along with a glass of water, and after another 15 minutes the rash was subsiding to a tolerable level. When she left I instructed her to keep Benadryl with her in case she needed another dose, and to not repeat Pfizer covid vaccinations in the future. (She reported no issues with previous Pfizer or flu shots.)
Intense pack pain, soreness to injection site (can not lift arm or touch the site), fatigue, feverish, chills.
1st shot 2019, is now here for 2nd shot; This case was reported by a pharmacist and described the occurrence of incomplete course of vaccination in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 20th December 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
Initial pain (dull ache) in my left shoulder that subsided after 48 hrs. unless I raise my arm 90° from my abdomen or pick up anything over 5 lbs. Reported to Moderna after 4 weeks of pain.. Seen by my GP  on 05/03/2021 who prescribed Naproxen. This did not help at all. I could not take steroids due to acute diverticulitis. Reported to Moderna again on 05/20/2021.
Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/28/2022 Discharge Date: Sep 4, 2022  PRESENTING PROBLEM: Acute hyponatremia [E87.1] Colitis [K52.9] Hyponatremia [E87.1] Vertebral artery dissection (HCC) [I77.74] COVID-19 [U07.1]   HOSPITAL COURSE: 83 year old female with history of hypertension and hyperlipidemia.  She was seen by her PCP 8/23 with complains of abdominal pain dysuria and was started on Bactrim.  She thought she was allergic to bactrim and stopped taking it.  She presented to the ED 8/27 and was discharged on Macrobid.  She presented to the ED 8/28 with 2 days of chills, rigors and malaise which worsened 24 hours prior to admission and worsening mental status.  On arrival to the ED a stroke code was called, CT head negative, CT angio head and neck showed concern for right cervical vertebral V2 segment dissection.  CT perfusion brain negative.  CT abdomen and pelvis showed left sided colitis.  Labs significant for sodium of 103.   She was given 100ml of 3% saline and admitted to the ICU for treatment of hyponatremia.  She remained on room air and asymptomatic from COVID standpoint.   Sodium continued to improve, but leveled off on 09/01/2022.  Salt tablets were added 3 times a day with noted improvement. Sodium was 134 on day of discharge and sodium tabs were decreased to BID and she was recommended to follow-up with her PCP in 1 week for repeat sodium check and determine at that time if sodium tablets could be discontinued.    Neurology was consulted in regards to her right cervical V2  segment dissection on CT and recommended ASA (81 mg daily) with outpatient follow-up with neurovascular clinic for repeat imaging in 3 months.    PT/OT evaluated patient and recommended home on discharge. Patient was discharged in stable condition and discharge instructions provided.
Child presents with finely dispensed macular rash to arms, buttocks, face and legs. Rash has been present x 1 week. Child is itching in areas, mother also states, child had 2-3 large areas with blistery appearance that has already scabbed and crusted. Afebrile . NP not available in clinic today, referred child to PMD for evaluation. Pt not in distress. Call to pt's mother, went to be evaluated by MD.
Patient states she has experienced fever, headache, injection site pain and redness starting the night of vaccination. The patient has taken Claritin and Motrin.